These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 2532634

  • 61. The development of an oral prodrug, SR-2545, of the 2-nitroimidazole radiosensitizer SR-2508.
    Coleman CN, Lee WW, Constine LS, Brown JM.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):431-4. PubMed ID: 6213588
    [Abstract] [Full Text] [Related]

  • 62. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y, Murayama C, Maezawa H, Mori T.
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [Abstract] [Full Text] [Related]

  • 63. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
    Ahmed I, Stratford IJ, Jenkins TC.
    Arzneimittelforschung; 1985 Oct; 35(12):1763-8. PubMed ID: 4096727
    [Abstract] [Full Text] [Related]

  • 64. A rapid-mix study on the effect of lipophilicity of nitroimidazoles on the radiosensitization of mammalian cells in vitro.
    Watts ME, Hodgkiss RJ, Jones NR, Sehmi DS, Woodcock M.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Mar; 43(3):329-36. PubMed ID: 6601082
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
    Overgaard J, Overgaard M, Nielsen OS, Pedersen AK, Timothy AR.
    Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
    [Abstract] [Full Text] [Related]

  • 67. Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
    Rockwell S.
    Br J Cancer Suppl; 1978 Jun; 3():212-5. PubMed ID: 277230
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Comparative study of thermoradiosensitization by misonidazole and metronidazole in vivo: antitumour effect and pharmacokinetics.
    Wong KH, Maezawa H, Urano M.
    Int J Hyperthermia; 1992 Jun; 8(5):645-58. PubMed ID: 1402141
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Misonidazole increases the toxicity of BCNU for hypoxic cells.
    Tannock I, Guttman P.
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(3-4):663-6. PubMed ID: 7107395
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation.
    Sasai K, Fushiki M, Yukawa Y, Suyama S, Iwai H, Shibamoto Y, Nishimoto S, Takahashi M, Abe M.
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1231-4. PubMed ID: 1938521
    [Abstract] [Full Text] [Related]

  • 77. Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards.
    Lee FY, Workman P.
    Cancer Chemother Pharmacol; 1986 Oct; 17(1):30-7. PubMed ID: 3698174
    [Abstract] [Full Text] [Related]

  • 78. Effects of oxygen and misonidazole on cell transformation and cell killing in C3H 10T1/2 cells by X rays in vitro.
    Borsa J, Sargent MD, Einspenner M, Azzam EI, Raaphorst GP.
    Radiat Res; 1984 Oct; 100(1):96-103. PubMed ID: 6494435
    [Abstract] [Full Text] [Related]

  • 79. [Synthesis of 1-substituted nitroimidazoles and its evaluation as radiosensitizing agents].
    Adams DR, Martul R, Alvarez MV, López Zumel MC, Espada M.
    Acta Cient Venez; 1991 Oct; 42(5):257-65. PubMed ID: 1843567
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.